T-cell quality in memory and protection: implications for vaccine design

RA Seder, PA Darrah, M Roederer - Nature Reviews Immunology, 2008 - nature.com
T cells mediate effector functions through a variety of mechanisms. Recently, multiparameter
flow cytometry has allowed a simultaneous assessment of the phenotype and multiple …

Heterologous prime–boost vaccination

S Lu - Current opinion in immunology, 2009 - Elsevier
An effective vaccine usually requires more than one time immunization in the form of prime–
boost. Traditionally the same vaccines are given multiple times as homologous boosts. New …

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

E Zhao, T Maj, I Kryczek, W Li, K Wu, L Zhao, S Wei… - Nature …, 2016 - nature.com
Aerobic glycolysis regulates T cell function. However, whether and how primary cancer
alters T cell glycolytic metabolism and affects tumor immunity in cancer patients remains a …

Dominant TNF-α+Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

A Harari, V Rozot, FB Enders, M Perreau, JM Stalder… - Nature medicine, 2011 - nature.com
Rapid diagnosis of active Mycobacterium tuberculosis (Mtb) infection remains a clinical and
laboratory challenge. We have analyzed the cytokine profile (interferon-γ (IFN-γ), tumor …

Viruses as vaccine vectors for infectious diseases and cancer

SJ Draper, JL Heeney - Nature Reviews Microbiology, 2010 - nature.com
Recent developments in the use of viruses as vaccine vectors have been facilitated by a
better understanding of viral biology. Advances occur as we gain greater insight into the …

Technologies for enhanced efficacy of DNA vaccines

F Saade, N Petrovsky - Expert review of vaccines, 2012 - Taylor & Francis
Despite many years of research, human DNA vaccines have yet to fulfill their early promise.
Over the past 15 years, multiple generations of DNA vaccines have been developed and …

The evolution of poxvirus vaccines

L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez… - Viruses, 2015 - mdpi.com
After Edward Jenner established human vaccination over 200 years ago, attenuated
poxviruses became key players to contain the deadliest virus of its own family: Variola virus …

Challenges in the development of an HIV-1 vaccine

DH Barouch - Nature, 2008 - nature.com
The development of a safe and effective human immunodeficiency virus (HIV)-1 vaccine is a
critically important global health priority. Despite recent advances in our understanding of …

High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival

DT Utzschneider, F Alfei, P Roelli, D Barras… - Journal of Experimental …, 2016 - rupress.org
Chronic infections induce T cells showing impaired cytokine secretion and up-regulated
expression of inhibitory receptors such as PD-1. What determines the acquisition of this …

The role of antibodies in HIV vaccines

JR Mascola, DC Montefiori - Annual review of immunology, 2009 - annualreviews.org
Licensed vaccines against viral diseases generate antibodies that neutralize the infecting
virus and protect against infection or disease. Similarly, an effective vaccine against HIV-1 …